When bacteria are buckling

Filamentous cyanobacteria buckle at a certain length when they encounter an obstacle. This was discovered by the research group of Stefan Karpitschka, group leader at the Max Planck Institute for Dynamics and Self-Organization and professor at the University of Konstanz. The results provide an important basis for the use of cyanobacteria in modern biotechnology.

Background Research:

The research group led by Stefan Karpitschka, from the Max Planck Institute for Dynamics and Self-Organization and University of Konstanz, discovered that filamentous cyanobacteria buckle when they encounter obstacles at a certain length. Cyanobacteria are one of the largest groups of bacteria also known as blue-green algae. They use sunlight to make their own food which makes them crucial in our ecosystem as primary producers.

Moreover, these bacteria have unique properties like producing future biofuels or biodegradable plastics making them valuable candidates for modern biotechnology applications.

Here are some FAQ’s based on this research:

1. What is cyanobacteria?
– Cyanobacteria is one of the largest and most important groups of bacteria found on Earth
also known as blue-green algae.

2. What discovery was made about cyanobacteria in this study?
– The study revealed that filamentous cyanobacteria buckle encountering an obstacle at a
certain length.

3. Why is this finding significant?
– Understanding the behavior and physical constraints of these organisms can help in their
efficient utilization in various modern biotechnological applications.

4. How does buckling bacteria affect its growth process?
– This remains speculative at present, more studies may offer insights into how such morphological changes impact growth patterns.

5.What are possible biotechnological uses for cyanobacteria?
– With unique properties like photosynthesis and oxygen production, potential uses could include biofuel production, waste treatment or even producing oxygen in space missions.

6.Who conducted this research and where was it conducted?
– The research was led by Group leader Stefan Karpitschka at the Max Planck Institute for
Dynamics and Self-Organization & professor at the University of Konstanz

7.Will there be further investigation following this discovery?
– While it can’t be confirmed without additional sources, advancements and discoveries
like this often lead to further research.

8.What obstacles do the bacteria encounter that cause them to buckle?
– It’s not stated explicitly in the press release. It could involve physical barriers or
chemical signals but more precise details could only be confirmed by reviewing the full
study.

9.Can I get more information about this?
– Yes, here is the link of the original Press Release: http://idw-online.de/de/news835352

10.How does this relate to previous studies and knowledge on cyanobacteria?
– The current information isn’t clear on that point. This discovery seems like a new aspect
of cyanobacteria behaviour which had not been highlighted before.

This research opens up more potential uses for cyanobacteria in biotechnology while procuring a better understanding of their behavioral pattern when they encounter obstacles at certain lengths.

Originamitteilung:

Filamentous cyanobacteria buckle at a certain length when they encounter an obstacle. This was discovered by the research group of Stefan Karpitschka, group leader at the Max Planck Institute for Dynamics and Self-Organization and professor at the University of Konstanz. The results provide an important basis for the use of cyanobacteria in modern biotechnology.

share this recipe:
Facebook
Twitter
Pinterest

Weitere spannende Artikel

Bioreactor Allows Automated Long-Term Culturing of Stem Cells

Human induced pluripotent stem cells (hiPSCs) are considered as a promising tool in medicine, with the potential to unlock treatments for many health conditions such as neurodegenerative diseases and disorders. However, producing large amounts of hiPSCs remains a challenge. Researchers from the Fraunhofer Translational Center for Regenerative Therapies TLC-RT at the Fraunhofer Institute for Silicate Research ISC have now developed a bioreactor that can be used for automated long-term culturing of hiPSCs.

Read More

Bioreaktor ermöglicht automatisierte Langzeitkultivierung von Stammzellen

Humane induzierte pluripotente Stammzellen (hiPSCs) gelten als vielversprechendes Werkzeug in der Medizin: Künftig sollen sie die Therapie von vielen Leiden wie etwa neurodegenerativen Erkrankungen ermöglichen. Nach wie vor ist jedoch die Herstellung großer Mengen an hiPSCs eine Herausforderung. Forschende des Fraunhofer-Translationszentrums für Regenerative Therapien TLZ-RT am Fraunhofer-Institut für Silicatforschung ISC haben nun einen Bioreaktor entwickelt, mit dem eine automatisierte Langzeitkultivierung von hiPSCs gelingt.

Read More